Clinical Platforms
Why Clinical Trial Platforms Must Evolve from Tools to Strategy
Chris Driver
IQVIA
PAO-07-25-CL-03Jul 18, 2025
Announcement
AccessDx Laboratory Announces Integration with PointClickCare
AccessDx Laboratory
PR-02-25-NI-20Feb 19, 2025
Antibody-Drug Conjugates
Reducing ADC Development Timelines with Integrated Development and Manufacturing Services
Thomas Rohrer
Samsung Biologics
PAO-11-23-CL-01Nov 13, 2023
Decentralized Clinical Trials
Innovating DCTs Through Application and Cross-Functional Delivery
Jennifer Crager; Sandra Orset, Ph.D.
PPD clinical research business of Thermo Fisher Scientific
PAO-07-23-CL-02Aug 29, 2023
Expanded CDMO Capabilities
On the Journey to Support Drug Developers With End-to-End Outsourcing
Michelle Hall
Mikart
PAO-06-23-CL-04Jul 17, 2023
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03Mar 14, 2023
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04May 9, 2022
mRNA Vaccine Manufacturing
Presenting an Integrated Solution for mRNA Vaccine Manufacturing
Mark Bamforth; Dave Stevens
Kincell Bio
PAO-01-22-R250-04Jan 26, 2022
mRNA Manufacturing
Integrating a Fragmented mRNA Supply Chain
Dave Stevens
Arranta Bio
PAO-11-21-CL-04Nov 22, 2021
Streamlining OSD Operations from Tableting through Serialization
Richard Walkup
Avara Pharmaceutical Services
PA789Oct 21, 2021
Antibody–Drug Conjugates
Preparing for the ADC Explosion with End-to-End Support
Elizabeth McKee; Jyothi Swamy, Ph.D.
MilliporeSigma
PAP-Q4-20-CL-014Dec 9, 2020
The Future of Healthcare
How Does Polpharma Biologics Envision the Future of the Pharma/Biopharma Industry?
Polpharma Biologics
PAP-Q4-20-RT2-010Dec 9, 2020
Industry Leader Insight
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
Magnus Schroeder, Ph.D.
Avid Bioservices
PAP-Q2-20-CL-002Jul 1, 2020
Integration
Creating Value through Best Practices Across a Global, Integrated Service Provider
Jeffrey Butler, Ph.D.
AMPAC Fine Chemicals
PAP-Q2-20-CL-009Jul 1, 2020
HPAPIs
Essentials of an Industry-Leading CDMO Partner for Highly Potent Projects
Brian P. Haney, Ph.D.
Curia (formerly AMRI)
PAP-Q2-20-CL-031Jul 1, 2020
Integration
True Integration is Integral to Providing One-Stop-Shop CDMO Services
Stuart E. Needleman
Piramal Pharma Solutions
PAP-Q3-19-CL-022Oct 28, 2019
Fermentation
Supporting Customers with an Integrated Fermentation Offering
Giovanni Celeste
Olon
PAP-Q3-19-CL-020Oct 28, 2019
Integration
Building Upon an Integrated Biologics Offering
Catalent
PTV-M08-19-BIO-005Aug 12, 2019
Integration
Strengthening the Outsource Service Offering through Integration
Luigi Trussardo
Olon
PAP-Q2-18-CL-013May 29, 2018
CRDMO
Creating a Global C‘R’DMO for the Future of (Bio)pharma: Effective Strategies and Tactics
Steven R. Hagen, Ph.D.; Dawn Von Rohr
Curia (formerly AMRI)
PAP-Q03-16-CL-001Aug 1, 2016